The business of curing diseases can be a lucrative one, and investors will jump on the bandwagon for any stock that shows the promise of a big breakthrough. Biotech is in its early growth phase. In a few short years, twentieth-century health care methodologies will seem medieval and archaic. BY the middle of the current [...]